Soleon Life Sciences India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 29-12-2024
- Paid Up Capital ₹ 1.00 M
as on 29-12-2024
- Company Age 8 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 38.45%
(FY 2020)
- Profit -3035.70%
(FY 2020)
- Ebitda -2714.74%
(FY 2020)
- Net Worth -161.96%
(FY 2020)
- Total Assets 63.70%
(FY 2020)
About Soleon Life Sciences India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Rajender Singh and Yogendra Choudhry serve as directors at the Company.
- CIN/LLPIN
U74999UP2016PTC086196
- Company No.
086196
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Sep 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Soleon Life Sciences India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajender Singh  | Director | 21-Nov-2019 | Current |
| Yogendra Choudhry | Director | 23-Nov-2018 | Current |
Financial Performance of Soleon Life Sciences India.
Soleon Life Sciences India Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 38.45% increase. The company also saw a substantial fall in profitability, with a 3035.7% decrease in profit. The company's net worth observed a substantial decline by a decrease of 161.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Soleon Life Sciences India?
In 2020, Soleon Life Sciences India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Totaltech Engineering (Opc) Private LimitedActive 8 years 4 monthsYogendra Choudhry is a mutual person
Vijayaveda Biotech LimitedActive 3 years 9 monthsRajender Singh and Yogendra Choudhry are mutual person
- Traio Machines Private LimitedActive 11 years 8 months
Rajender Singh and Yogendra Choudhry are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Soleon Life Sciences India?
Unlock and access historical data on people associated with Soleon Life Sciences India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Soleon Life Sciences India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Soleon Life Sciences India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
